Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Up 755.8% in October
by Danessa Lincoln · The Markets DailySino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totalling 1,203,300 shares, an increase of 755.8% from the September 30th total of 140,600 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.
Sino Biopharmaceutical Stock Performance
Sino Biopharmaceutical stock remained flat at $0.47 during mid-day trading on Friday. The firm has a 50 day moving average price of $0.42 and a two-hundred day moving average price of $0.37. Sino Biopharmaceutical has a 1-year low of $0.31 and a 1-year high of $0.49.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand.
See Also
- Five stocks we like better than Sino Biopharmaceutical
- What is a Special Dividend?
- Texas Roadhouse Stock Steering for New Highs This Year
- There Are Different Types of Stock To Invest In
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Retail Stocks Investing, Explained
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity